The Watson family and management team are happy to announce that Watson is now part of Glanbia Nutritionals (a wholly-owned subsidiary of Glanbia plc) a company whose values, culture and purpose match those of Watson Inc. With the combined portfolios, expertise, and manufacturing capability, Watson customers now have access to more technologies, more knowledge, and better solutions.
Glanbia Nutritionals is a $1.4bn [€1.2bn] nutritional solutions and cheese business with over 2,000 employees and a presence in 19 countries. The Glanbia offering includes proteins, custom nutrient premixes, cheese, bioactives, plant-based nutrition ingredients, flavors, micronutrients, and aseptic beverage manufacturing. Their products are sold in over 130 countries worldwide into mainstream food and beverage, sports nutrition, clinical nutrition, infant nutrition, supplements, personal care, and animal nutrition markets. For more information visit www.glanbianutritionals.com.
The acquisition of Watson completes a U.S. coast-to-coast ingredient solutions footprint with Watson’s two micronutrient manufacturing facilities in Connecticut and Illinois joining with Glanbia’s two facilities in California and Missouri. In addition to full coverage in the U.S, Watson customers will have more flexibility than ever on a global scale with Glanbia’s micronutrient ingredient facilities in Germany and China.
The Watson leadership team will remain with the Glanbia Nutritionals organization, ensuring a seamless experience for Watson Customers.
“We are excited to welcome the 300 employees of Watson with their established reputation of expertise, technical capability, and commitment to excellence,” said Brian Phelan, CEO of Glanbia Nutritionals. “The customers of both organizations will stand to benefit significantly from the combined capabilities that the two teams now bring together.”
“We believe that a combination of Watson and Glanbia will offer more growth and long-term opportunities for Watson, its customers, and employees,” said James Watson, President of Watson Inc. “This is a defining moment in the growth of Watson as a business. We look forward to the next chapter of our story.”
New shelter data casts doubt on whether the pet population and pet ownership are truly growing.
While the pandemic caused unprecedented suffering worldwide in 2020, the disruptions to dogs, cats and other pets adoption numbers may normalize in 2021.